Corbus Pharmaceuticals Holdings Inc. (CRBP) SEC News Oct. 30, 2025, 20:33 UTC 4 0 comments New Form 424B5 - Corbus Pharmaceuticals Holdings, Inc. Filed: 2025-10-30 AccNo: 0001193125-25-258685 Size: 971 KB Comment Full text
89bio Inc (ETNB) SEC News Oct. 30, 2025, 20:32 UTC 2 0 comments New Form S-8 POS - 89bio, Inc. Filed: 2025-10-30 AccNo: 0001193125-25-258676 Size: 26 KB Comment Full text
Rani Therapeutics LLC (RANI) SEC News Oct. 30, 2025, 20:31 UTC 2 1 comments Bailey Vasudev Jaiprakash 🟢 acquired 100.0K shares (1 derivative) of Rani Therapeutics Holdings, Inc. (RANI) at $2.09 Transaction Date: Oct 23, 2025 | Filing ID: 000004 Comment Full text
Rani Therapeutics LLC (RANI) SEC News Oct. 30, 2025, 20:31 UTC 4 0 comments New Form 3 - Rani Therapeutics Holdings, Inc. Filed: 2025-10-30 AccNo: 0002094741-25-000002 Size: 8 KB Comment Full text
Regional Health Properties Inc (RHE$A) SEC News Oct. 30, 2025, 20:31 UTC 3 0 comments New Form 8-K/A - REGIONAL HEALTH PROPERTIES, INC Filed: 2025-10-30 AccNo: 0001493152-25-020243 Size: 625 KB Item 9.01: Financial Statements and Exhibits Comment Full text
Incyte Corporation (INCY) SEC News Oct. 30, 2025, 20:31 UTC 3 1 comments 📋 CHRISTIANA STAMOULIS (Officer) plans to sell 15K shares of INCYTE CORPORATION (at $94.00 each, total $1.4M) Filed: Oct 30, 2025 | ID: 008301 Comment Full text
United Therapeutics Corporation (UTHR) SEC News Oct. 30, 2025, 20:30 UTC 3 1 comments ROTHBLATT MARTINE A 🟡 adjusted position in 8.0K shares (2 derivative) of UNITED THERAPEUTICS Corp (UTHR) at $420.29 ($5.2M) Transaction Date: Oct 27, 2025 | Filing ID: 000024 Comment Full text
Aptevo Therapeutics Inc. (APVO) SEC News Oct. 30, 2025, 20:30 UTC 3 1 comments (99% Neutral) APTEVO THERAPEUTICS INC. (APVO) Announces Business Combination Comment Full text
Novavax Inc (NVAX) SEC News Oct. 30, 2025, 20:30 UTC 3 1 comments Director Rodgers Richard J 🟡 adjusted position in 0 shares (1 derivative) of NOVAVAX INC (NVAX) Transaction Date: Oct 29, 2025 | Filing ID: 104413 Comment Full text
Vir Biotechnology (VIR) SEC News Oct. 30, 2025, 20:30 UTC 3 1 comments SVF Endurance (Cayman) Ltd 🔴 sold 24.6K shares of Vir Biotechnology, Inc. (VIR) at $6.50 Transaction Date: Oct 28, 2025 | Filing ID: 020240 Comment Full text